Literature DB >> 16183045

Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model.

Jun-ichi Hinagata1, Makoto Kakutani, Takao Fujii, Takahiko Naruko, Nobutaka Inoue, Yoshiko Fujita, Jawahar L Mehta, Makiko Ueda, Tatsuya Sawamura.   

Abstract

OBJECTIVE: LOX-1 is a multi-ligand receptor originally identified as the endothelial oxidized LDL receptor. LOX-1 expression is also induced in smooth muscle cells in response to proinflammatory and oxidative stimuli. Here, we report on the role of LOX-1 in intimal hyperplasia, in which proinflammatory and oxidative stimuli are increased. METHODS AND
RESULTS: Left common carotid artery of rat was injured by a balloon catheter. The expression of LOX-1 was significantly increased within 24 h after the balloon injury and peaked at day 7. LOX-1 expression was observed predominantly in medial smooth muscle cells until day 3, and then shifted to predominantly intimal smooth muscle cells. At day 14, the expression was concentrated in the regenerated endothelial cells. To examine the contributory role of LOX-1 in the growth of intimal smooth muscle cells, rats were administered anti-LOX1 antibody intravenously every 3 days after balloon injury. Anti-LOX-1 antibody administration effectively suppressed intimal hyperplasia, oxidative stress, and leukocyte infiltration compared with control IgG. These findings suggest the importance of LOX-1 expression in the pathogenesis of neointimal formation in conjunction with oxidative stress and leukocyte infiltration.
CONCLUSION: The LOX-1 expressed in smooth muscle cells is involved in intimal hyperplasia in a rat model of balloon injury. Manipulation of LOX-1 activity is a novel potential therapeutic target to prevent restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183045     DOI: 10.1016/j.cardiores.2005.08.013

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.

Authors:  Hongfeng Wang; Dorothee Weihrauch; Judy R Kersten; Jeffrey M Toth; Anthony G Passerini; Anita Rajamani; Sonja Schrepfer; John F LaDisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

Review 3.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 4.  Oxidative Stress in Atherosclerosis.

Authors:  Ajoe John Kattoor; Naga Venkata K Pothineni; Deepak Palagiri; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-09-18       Impact factor: 5.113

5.  Sleeve gastrectomy prevents lipoprotein receptor-1 expression in aortas of obese rats.

Authors:  Jie Bai; Yong Wang; Yuan Liu; Dong-Hua Geng; Jin-Gang Liu
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

6.  Expression of transforming growth factor beta 1-related signaling proteins in irradiated vessels.

Authors:  Raimund H M Preidl; Patrick Möbius; Manuel Weber; Kerstin Amann; Friedrich W Neukam; Andreas Schlegel; Falk Wehrhan
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621

7.  LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men.

Authors:  Tomonori Okamura; Akira Sekikawa; Tatsuya Sawamura; Takashi Kadowaki; Emma Barinas-Mitchell; Rachel H Mackey; Aya Kadota; Rhobert W Evans; Daniel Edmundowicz; Aya Higashiyama; Yasuyuki Nakamura; Robert D Abbott; Katsuyuki Miura; Akira Fujiyoshi; Yoshiko Fujita; Yoshitaka Murakami; Naomi Miyamatsu; Akemi Kakino; Hiroshi Maegawa; Kiyoshi Murata; Minoru Horie; Kenichi Mitsunami; Atsunori Kashiwagi; Lewis H Kuller; Hirotsugu Ueshima
Journal:  Atherosclerosis       Date:  2013-04-30       Impact factor: 5.162

Review 8.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

9.  Generation and characterization of chicken monoclonal antibodies against human LOX-1.

Authors:  Shin Iwamoto; Norihisa Nishimichi; Yoshiko Tateishi; Yuko Sato; Hiroyuki Horiuchi; Shuichi Furusawa; Tatsuya Sawamura; Haruo Matsuda
Journal:  MAbs       Date:  2009 Jul-Aug       Impact factor: 5.857

Review 10.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.